| Filed On | Filing |
|---|---|
| 16 Oct 2026 | SC TO-I |
| 01 Oct 2026 | SC TO-C |
| 17 Sep 2026 |
Form 3: Mahoney Francis C., Director
No securities owned |
| 03 Sep 2026 | BLACKROCK HEALTH SCIENCES TERM TRUST |
| 28 Aug 2026 | N-PX |
| 25 Aug 2026 | NPORT-P |
| 05 Aug 2026 |
Form 3: Park Charles, Chief Compliance Officer
No securities owned |
| 02 Jun 2026 | Proxy statement: annual meeting on July 22, 2026 |
| 28 May 2026 | NPORT-P |
| 13 Mar 2026 | N-CEN |
| 05 Mar 2026 | BLACKROCK HEALTH SCIENCES TERM TRUST |
| 24 Feb 2026 | NPORT-P |
| 03 Feb 2026 |
Form 4: Liu Xiang, Portfolio Manager
Received 777.9221 shares by exercise or conversion · Returned 777.9221 shares to the issuer ($11.8K) · Granted 1,026.693 Phantom Shares ($15.6K) |
| 03 Feb 2026 |
Form 4: Xie H Erin, Portfolio Manager
Received 25,676.2744 shares by exercise or conversion · Returned 25,676.2744 shares to the issuer ($391K) · Granted 17,560.4931 Phantom Shares ($267K) |
| 23 Jan 2026 | FIDELITY BOND - 40-17G |
| 22 Dec 2025 |
Form 4: Fairbairn Robert W, Director
Sold 20,588 shares ($308K) · Sold 0.844 shares ($12.6) |
| 26 Nov 2025 | NPORT-P |
| 04 Sep 2025 | BLACKROCK HEALTH SCIENCES TERM TRUST |
| 28 Aug 2025 | N-PX |
| 26 Aug 2025 | NPORT-P |
Loading...
